Total amount: € 0,00
Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014
Online ISSN 1827-1820
Andrea BASSI 1, Piero CAMPOLMI 2, Margherita DINDELLI 1, Nicola BRUSCINO 1, Rossana CONTI 1, Giovanni CANNAROZZO 1, Nicola PIMPINELLI 2
1 Section of Dermatology, Department of Surgery and Translational Medicine, University of Florence Medical School, Florence, Italy; 2 Dermatology and Physical Therapy Unit, ASL Firenze, Florence, Italy
BACKGROUND: Rhinophyma is a benign, disfiguring disorder, commonly referred to as the end-stage of severe rosacea and characterized by a progressive thickening and hypertrophy of the nasal skin and soft tissues. The aim of this paper was to evaluate the efficacy of CO2 laser compared to other laser techniques and surgical methods in the treatment of rhinophyma.
METHODS: Twenty-four rhinophyma patients were treated with CO2 laser in our institution from 2003 to 2013. A 10,600-nm CO2 pulsed laser was used in all patients, with a 6-month, post-treatment follow-up.
RESULTS: Six months after the last laser session, all patients showed global improvement of their clinical conditions: 19 (79.1%) high improvement (>75%), 4 (16.7%) moderate improvement (50-75%), and 1 (4.2%) low improvement (<25%).
CONCLUSIONS: Our study demonstrates that carbon dioxide laser warrants a careful nasal surface ablation, allowing the remodeling of the hypertrophic areas, with an excellent cosmetic result, a very short healing time, and virtually no side effects.